{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:40:33Z","timestamp":1789609233584,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.humimm.2019.04.005","type":"journal-article","created":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T16:14:58Z","timestamp":1555776898000},"page":"573-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Proactive treatment of angiotensin receptor antibodies in kidney transplantation with plasma exchange and\/or candesartan is safe and associated with excellent graft survival at 4\u202fyears: A single centre Australian experience"],"prefix":"10.1016","volume":"80","author":[{"given":"Robert P","family":"Carroll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Deayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Emery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Watsala","family":"Munasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Tsiopelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Fleet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meg","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maisarah","family":"Jalalonmuhali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.humimm.2019.04.005_b0005","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.kint.2016.03.019","article-title":"Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity","volume":"90","author":"Dragun","year":"2016","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.humimm.2019.04.005_b0010","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/TP.0b013e3181fd97f1","article-title":"Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients","volume":"90","author":"Reinsmoen","year":"2010","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.humimm.2019.04.005_b0015","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/ajt.12395","article-title":"Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies","volume":"13","author":"Taniguchi","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2019.04.005_b0020","doi-asserted-by":"crossref","DOI":"10.1111\/nep.12441","article-title":"C4d Negative antibody mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor specific antibodies","author":"Fuss","year":"2015","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.humimm.2019.04.005_b0025","first-page":"434","article-title":"Impact of Non-human leukocyte antigen-specific antibodies in kidney and heart transplantation","volume":"8","author":"Zhang","year":"2017","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.humimm.2019.04.005_b0030","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.humimm.2016.08.009","article-title":"Angiotensin II type-1 receptor antibody (AT1Rab) associated humoral rejection and the effect of peri operative plasma exchange and candesartan","volume":"77","author":"Carroll","year":"2016","journal-title":"Hum. Immunol."},{"issue":"11","key":"10.1016\/j.humimm.2019.04.005_b0035","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13407","article-title":"Detection of Angiotensin II type I-receptor antibodies in transplant glomerulopathy","volume":"32","author":"Bussolino","year":"2018","journal-title":"Clin. Transplant."},{"issue":"1","key":"10.1016\/j.humimm.2019.04.005_b0040","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.kint.2017.06.034","article-title":"Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation","volume":"93","author":"Pearl","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.humimm.2019.04.005_b0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.trim.2017.12.001","article-title":"Pre-transplant AT1R antibodies correlate with early allograft rejection","volume":"46","author":"Gareau","year":"2018","journal-title":"Transplant. Immunol."},{"key":"10.1016\/j.humimm.2019.04.005_b0050","article-title":"Pretransplant angiotensin ii type 1-receptor antibodies point to an increase in renal graft sub-intimal fibrosis in living- donor kidney transplant recipients","author":"Gonzalez-Almada","year":"2018","journal-title":"Transplant. Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2019.04.005_b0055","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/ndt\/gfy008","article-title":"Association of angiotensin II type 1 receptor antibodies with graft histology, function and survival in paediatric renal transplant recipients","volume":"33","author":"Fichtner","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.humimm.2019.04.005_b0060","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.humimm.2018.02.001","article-title":"Pre-transplant screening for non-HLA antibodies: who should be tested?","volume":"79","author":"Philogene","year":"2018","journal-title":"Hum. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2019.04.005_b0065","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ki.2013.117","article-title":"Sequential analysis of donor-specific antibodies and pathological findings in acute antibody-mediated rejection in a rat renal transplantation model","volume":"84","author":"Kohei","year":"2013","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.humimm.2019.04.005_b0070","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/01.tp.0000287457.54761.53","article-title":"The involvement of FcR mechanisms in antibody-mediated rejection","volume":"84","author":"Lee","year":"2007","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.humimm.2019.04.005_b0075","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/ki.2013.300","article-title":"Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies","volume":"85","author":"Halloran","year":"2014","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.humimm.2019.04.005_b0080","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.kint.2016.02.030","article-title":"Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts","volume":"89","author":"Kohei","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.humimm.2019.04.005_b0085","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.healun.2012.01.116","article-title":"112 Identification of non-HLA antibodies in ventricular assist device recipients","volume":"31","author":"Barten","year":"2012","journal-title":"J. Heart Lung Transplant."},{"issue":"1","key":"10.1016\/j.humimm.2019.04.005_b0090","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1038\/s41467-018-07598-9","article-title":"GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis","volume":"9","author":"Cabral-Marques","year":"2018","journal-title":"Nat. Commun."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885919301739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885919301739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:51:35Z","timestamp":1759319495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885919301739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0198885919301739"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2019.04.005","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proactive treatment of angiotensin receptor antibodies in kidney transplantation with plasma exchange and\/or candesartan is safe and associated with excellent graft survival at 4\u202fyears: A single centre Australian experience","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2019.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.","name":"copyright","label":"Copyright"}]}}